Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility

Michael Camilleri, R. K. Balm, A. R. Zinsmeister

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aim: To assess the efficacy of a prokinetic agent in the long-term treatment of chronic intestinal dysmotility and the influence of extrinsic denervation. Methods: We assessed symptoms, compliance and untoward effects in an open, 1-year trial of cisapride, 20 mg t.d.s., in 37 patients with neuropathic forms of chronic intestinal dysmotility. Patients' autonomic function had previously been characterized; effects of cisapride at 12 weeks in a placebo-controlled trial were previously reported. Results: Seventeen patients had idiopathic dysmotility, 11 had diabetes mellitus with autonomic dysfunction, five had had previous gastric surgery and four had neurological syndromes. Medial medication compliance was 98.9% for the study period completed by each individual. Median duration of follow-up was 9.5 months; 20 patients completed 1 year of treatment, and 27 of 37 at least 6 months of treatment; seven dropped out because of lack of benefit. Mean total symptom score was significantly reduced at the last observation relative to the entry into the trial; this was particularly the case in those patients without abdominal vagal dysfunction. One patient withdrew because of aggravation of abdominal pain. Conclusions: During an open, long-term trial, cisapride, 20 mg t.d.s., provided continued symptomatic relief to patients with chronic intestinal dysmotility, particularly those without vagal neuropathy.

Original languageEnglish (US)
Pages (from-to)403-409
Number of pages7
JournalAlimentary Pharmacology and Therapeutics
Volume10
Issue number3
DOIs
StatePublished - 1996

Fingerprint

Cisapride
Therapeutics
Medication Adherence
Denervation
Abdominal Pain
Compliance
Stomach
Diabetes Mellitus
Placebos
Observation

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. / Camilleri, Michael; Balm, R. K.; Zinsmeister, A. R.

In: Alimentary Pharmacology and Therapeutics, Vol. 10, No. 3, 1996, p. 403-409.

Research output: Contribution to journalArticle

@article{2e36b357b5594bf4b0cb69ad5eceaeef,
title = "Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility",
abstract = "Aim: To assess the efficacy of a prokinetic agent in the long-term treatment of chronic intestinal dysmotility and the influence of extrinsic denervation. Methods: We assessed symptoms, compliance and untoward effects in an open, 1-year trial of cisapride, 20 mg t.d.s., in 37 patients with neuropathic forms of chronic intestinal dysmotility. Patients' autonomic function had previously been characterized; effects of cisapride at 12 weeks in a placebo-controlled trial were previously reported. Results: Seventeen patients had idiopathic dysmotility, 11 had diabetes mellitus with autonomic dysfunction, five had had previous gastric surgery and four had neurological syndromes. Medial medication compliance was 98.9{\%} for the study period completed by each individual. Median duration of follow-up was 9.5 months; 20 patients completed 1 year of treatment, and 27 of 37 at least 6 months of treatment; seven dropped out because of lack of benefit. Mean total symptom score was significantly reduced at the last observation relative to the entry into the trial; this was particularly the case in those patients without abdominal vagal dysfunction. One patient withdrew because of aggravation of abdominal pain. Conclusions: During an open, long-term trial, cisapride, 20 mg t.d.s., provided continued symptomatic relief to patients with chronic intestinal dysmotility, particularly those without vagal neuropathy.",
author = "Michael Camilleri and Balm, {R. K.} and Zinsmeister, {A. R.}",
year = "1996",
doi = "10.1111/j.0953-0673.1996.00403.x",
language = "English (US)",
volume = "10",
pages = "403--409",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility

AU - Camilleri, Michael

AU - Balm, R. K.

AU - Zinsmeister, A. R.

PY - 1996

Y1 - 1996

N2 - Aim: To assess the efficacy of a prokinetic agent in the long-term treatment of chronic intestinal dysmotility and the influence of extrinsic denervation. Methods: We assessed symptoms, compliance and untoward effects in an open, 1-year trial of cisapride, 20 mg t.d.s., in 37 patients with neuropathic forms of chronic intestinal dysmotility. Patients' autonomic function had previously been characterized; effects of cisapride at 12 weeks in a placebo-controlled trial were previously reported. Results: Seventeen patients had idiopathic dysmotility, 11 had diabetes mellitus with autonomic dysfunction, five had had previous gastric surgery and four had neurological syndromes. Medial medication compliance was 98.9% for the study period completed by each individual. Median duration of follow-up was 9.5 months; 20 patients completed 1 year of treatment, and 27 of 37 at least 6 months of treatment; seven dropped out because of lack of benefit. Mean total symptom score was significantly reduced at the last observation relative to the entry into the trial; this was particularly the case in those patients without abdominal vagal dysfunction. One patient withdrew because of aggravation of abdominal pain. Conclusions: During an open, long-term trial, cisapride, 20 mg t.d.s., provided continued symptomatic relief to patients with chronic intestinal dysmotility, particularly those without vagal neuropathy.

AB - Aim: To assess the efficacy of a prokinetic agent in the long-term treatment of chronic intestinal dysmotility and the influence of extrinsic denervation. Methods: We assessed symptoms, compliance and untoward effects in an open, 1-year trial of cisapride, 20 mg t.d.s., in 37 patients with neuropathic forms of chronic intestinal dysmotility. Patients' autonomic function had previously been characterized; effects of cisapride at 12 weeks in a placebo-controlled trial were previously reported. Results: Seventeen patients had idiopathic dysmotility, 11 had diabetes mellitus with autonomic dysfunction, five had had previous gastric surgery and four had neurological syndromes. Medial medication compliance was 98.9% for the study period completed by each individual. Median duration of follow-up was 9.5 months; 20 patients completed 1 year of treatment, and 27 of 37 at least 6 months of treatment; seven dropped out because of lack of benefit. Mean total symptom score was significantly reduced at the last observation relative to the entry into the trial; this was particularly the case in those patients without abdominal vagal dysfunction. One patient withdrew because of aggravation of abdominal pain. Conclusions: During an open, long-term trial, cisapride, 20 mg t.d.s., provided continued symptomatic relief to patients with chronic intestinal dysmotility, particularly those without vagal neuropathy.

UR - http://www.scopus.com/inward/record.url?scp=0030011445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030011445&partnerID=8YFLogxK

U2 - 10.1111/j.0953-0673.1996.00403.x

DO - 10.1111/j.0953-0673.1996.00403.x

M3 - Article

C2 - 8791970

AN - SCOPUS:0030011445

VL - 10

SP - 403

EP - 409

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 3

ER -